Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
ACS Chemical Neuroscience|March 2, 2016
An ex Vivo Model for Evaluating Blood-Brain Barrier Permeability, Efflux, and Drug MetabolismKarin Hellman, Peter Aadal Nielsen, Fredrik Ek, et al.
Biochimica Et Biophysica Acta|September 13, 2015
An invertebrate model for CNS drug discovery: Transcriptomic and functional analysis of a mammalian P-glycoprotein orthologSonia Al-Qadi, Morten Schiøtt, Steen Honoré Hansen, et al.
Drug Discovery Today|April 26, 2011
Models for predicting blood-brain barrier permeationPeter Aadal Nielsen, Olga Andersson, Steen Honoré Hansen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 2014
Identification of a functional homolog of the mammalian CYP3A4 in locustsLine Rørbæk Olsen, Charlotte Gabel-Jensen, Peter Aadal Nielsen, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonistsMartin Cooper, Jean-Marie Receveur, Emelie Bjurling, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonistsMarie Grimstrup, Jean-Marie Receveur, Øystein Rist, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2013
The grasshopper: a novel model for assessing vertebrate brain uptakeOlga Andersson, Steen Honoré Hansen, Karin Hellman, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrierJean-Marie Receveur, Anthony Murray, Jean-Michel Linget, et al.
Pharmacology Research & Perspectives|December 16, 2014
Characterization of a novel brain barrier ex vivo insect-based P-glycoprotein screening modelOlga Andersson, Liesbeth Badisco, Ane Håkansson Hansen, et al.
Pageof 1